Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer

Science
Dmitry LyumkisAndrew B Ward

Abstract

The HIV-1 envelope glycoprotein (Env) trimer contains the receptor binding sites and membrane fusion machinery that introduce the viral genome into the host cell. As the only target for broadly neutralizing antibodies (bnAbs), Env is a focus for rational vaccine design. We present a cryo-electron microscopy reconstruction and structural model of a cleaved, soluble Env trimer (termed BG505 SOSIP.664 gp140) in complex with a CD4 binding site (CD4bs) bnAb, PGV04, at 5.8 angstrom resolution. The structure reveals the spatial arrangement of Env components, including the V1/V2, V3, HR1, and HR2 domains, as well as shielding glycans. The structure also provides insights into trimer assembly, gp120-gp41 interactions, and the CD4bs epitope cluster for bnAbs, which covers a more extensive area and defines a more complex site of vulnerability than previously described.

References

Jul 1, 1987·The Journal of Cell Biology·R A Milligan, P F Flicker
May 22, 1997·Nature·W WeissenhornD C Wiley
Jun 5, 2003·Journal of Structural Biology·Joseph A Mindell, Nikolaus Grigorieff
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Oct 13, 2004·Journal of Structural Biology·C O S SorzanoA Pascual-Montano
Nov 24, 2004·Ultramicroscopy·Alex Stewart, Nikolaus Grigorieff
May 14, 2005·Journal of Structural Biology·Christian SulowayBridget Carragher
Nov 15, 2005·Science·Chih-chin HuangPeter D Kwong
Jul 11, 2006·Journal of Structural Biology·Nikolaus Grigorieff
Oct 13, 2006·Journal of Structural Biology·Duncan Sousa, Nikolaus Grigorieff
Nov 4, 2006·Nature Structural & Molecular Biology·John M Pascal, Tom Ellenberger
May 25, 2007·Nature·Andrea Chipman
Feb 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Xing ZhangNikolaus Grigorieff
Jun 10, 2008·Nature Protocols·Sjors H W ScheresRoberto Marabini
Jul 11, 2008·Nature·Jeffrey E LeeErica Ollmann Saphire
Aug 1, 2008·Nature·Jun LiuSriram Subramaniam
Mar 6, 2009·Journal of Structural Biology·Gabriel C LanderBridget Carragher
Jul 15, 2009·Journal of Molecular Biology·Frank DiMaioDavid Baker
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marie PanceraPeter D Kwong
Oct 5, 2010·Methods in Enzymology·Dmitry LyumkisBridget Carragher
Jun 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Audray HarrisSriram Subramaniam
Sep 24, 2011·Journal of Molecular Biology·Richard HendersonPeter B Rosenthal
Nov 25, 2011·Nature·Jason S McLellanPeter D Kwong
Dec 1, 2011·Proceedings of the National Academy of Sciences of the United States of America·Li LiuEdward A Berger
Feb 11, 2012·Methods in Molecular Biology·Lorenza Bordoli, Torsten Schwede
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Young Do KwonPeter D Kwong
Apr 10, 2012·Structure·Shenping WuYifan Cheng
Jul 19, 2012·PLoS Pathogens·Erin E H TranSriram Subramaniam
Jul 20, 2012·Nature
Jul 31, 2012·Nature Methods·Sjors H W Scheres, Shaoxia Chen
Sep 25, 2012·Journal of Structural Biology·Sjors H W Scheres
Oct 2, 2012·Structure·Melody G CampbellNikolaus Grigorieff

❮ Previous
Next ❯

Citations

Jul 6, 2014·PloS One·Tongqing ZhouPeter D Kwon
Mar 29, 2014·Current Opinion in HIV and AIDS·Quentin J Sattentau
Mar 29, 2014·Current Opinion in HIV and AIDS·George K LewisAnthony L Devico
May 27, 2014·Nature Medicine·Leslie GooJulie Overbaugh
Mar 5, 2014·Nature·Nicole A Doria-RoseJohn R Mascola
Nov 2, 2013·Science·Jean-Philippe JulienIan A Wilson
Feb 27, 2014·Proceedings of the National Academy of Sciences of the United States of America·Raffaello CimbroPaolo Lusso
Apr 8, 2014·Chemistry and Physics of Lipids·Beatriz ApellánizJosé L Nieva
Jul 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Daniela FeraStephen C Harrison
Oct 29, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jianhua Zhao, John L Rubinstein
Oct 9, 2014·Nature·Marie PanceraPeter D Kwong
Oct 9, 2014·Nature·Rogier W Sanders, John P Moore
Oct 23, 2013·Proceedings of the National Academy of Sciences of the United States of America·Rajesh P RingeJohn P Moore
Feb 19, 2016·Nature·Allison Ballandras-ColasAlan N Engelman
Nov 18, 2015·Immunological Investigations·Daniel Amsterdam
Mar 1, 2015·Expert Opinion on Therapeutic Targets·Priyamvada AcharyaPeter D Kwong
Sep 27, 2014·Viruses·Sara W BirdEric O Freed
Mar 13, 2014·Expert Review of Vaccines·Max Medina-RamírezPer Johan Klasse
Jun 13, 2015·International Journal of Molecular Sciences·Enrico MalitoMatthew J Bottomley
Feb 13, 2016·Trends in Immunology·Steven W de TaeyeRogier W Sanders
Jan 31, 2015·Cell·Rachel P GalimidiPamela J Bjorkman
Aug 25, 2015·Journal of Molecular Graphics & Modelling·Alexander M AndrianovAlexander V Tuzikov
Dec 30, 2015·Proceedings of the National Academy of Sciences of the United States of America·Philip R TedburyEric O Freed
Dec 17, 2014·Proceedings of the National Academy of Sciences of the United States of America·James M KovacsBing Chen
Nov 26, 2014·Proceedings of the National Academy of Sciences of the United States of America·Devin SokDennis R Burton
Sep 16, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jean-Philippe JulienIan A Wilson
Sep 29, 2015·The FEBS Journal·Katie J Doores
Apr 30, 2015·Science China. Life Sciences·Zene Matsuda
Dec 15, 2015·Expert Review of Vaccines·Kwinten Sliepen, Rogier W Sanders
Mar 5, 2016·Nature·Robert N KirchdoerferAndrew B Ward

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.